Search results
May 15, 2013 · NEW DELHI: Dinesh Thakur, the former Ranbaxy executive who pocketed Rs 244 crore ($48 million) for blowing the whistle on the dubious manufacturing practices of the country's largest drug maker, has made some of his peers and ex-colleagues turn green with envy. "I worked for the company for almost two decades.
Jun 17, 2019 · Dinesh Thakur is a former Ranbaxy executive who exposed the company's fraud and violations in drug data and manufacturing. He is also a public health advocate for affordable medicines and health policy reforms in the US and India.
Nov 6, 2013 · Ranbaxy Whistleblower Dinesh Thakur's blog, including Ranbaxy legal documents Generic drug companies, such as Ranbaxy, have to prove their drugs are "bioequivalent," which means they have the same ...
- 6 min
May 13, 2013 · Ranbaxy USA, a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, admitted to selling adulterated drugs and making false statements to the FDA. The company agreed to pay $500 million to resolve the criminal and civil charges.
Dinesh Thakur is a former Ranbaxy executive who blew the whistle on massive fraud at the pharma giant. An investigation sparked by Thakur’s exposé led to the...
- 75 min
- 134.5K
- newslaundry
May 12, 2019 · Eban's reporting tells that story, drawing on interviews with more than 240 people, including FDA inspectors and Dinesh Thakur, a former Ranbaxy chemical engineer and whistleblower.
People also ask
What happened to Ranbaxy?
Who is Dinesh Thakur?
Who is liable in Thakur v Ranbaxy Laboratories Limited?
Why did Dinesh Thakur pocket Rs 244 crore?
Mar 7, 2016 · Three years ago, Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to ...
